27 February 2019

My name is Inge van Oort and I am Dutch. I am oncological urologist, Dept. of Urology, theme Urological cancers.

When you were a kid what did you want to be when you grew up? Can you tell us something about your child years. 

As a child I wanted to be a pastry chef. I grew up in Groningen as the eldest of 3. My father was a dentist at the university hospital and my mother was a very active stay at home mom. I did gymnastics and trained up to 15 hours a week until sport injuries forced me to stop. After that I still was involved in lots of other sports. One of them being a statistician of the professional Basketballclub Donar in Groningen. School was okay, loved being around friends but had to workhard for my grades. Unfortunately I had to leave Groningen after my study but still visit this town frequently for family visits.

What was your previous academic training, where did you study and why that study? 

I studied Medicine at the University of Groningen, and after that urology at the CWZ and Radboudumc in Nijmegen. I studied medicine because (real cheesy) I wanted to cure patients (and of course find “the” treatment for cancer). Urology because that is the best versatile surgical specialism there is, where you do a lot of diagnosing yourself (i.e. ultrasound, cystoscopy) then the surgical treatment or systemic treatment and see the patients for years in follow-up. After years you really get to know these patients and their family and that is very valuable.

The RIMLS motto is: ‘Today’s molecules for tomorrow’s medicine’. What does this mean for you? 

This means that the research we do should lead to use in clinical practice because that’s the aim I have as a clinician.

Who is your great example as scientists? And please give a motivation why.

My biggest inspiration as a scientist is Jack Schalken. He was the one who got me interested in urological research. His drive and motivation for urological science is inspirational and although he’s not a clinician he always thinks of research that can help the clinician and the patient. So a really good example of a scientist who thinks and works from bench to bedsite.  

Which research discovery that you have made has made you most proud? 

Both the PCA3 and the select MDx urine test who are now used in clinical practice in urology all over the world makes me proud as a scientist. 

Given unlimited finance what experiment would you perform?

Then I would sequence all my prostate cancer patients to get more insight in the best treatment options for personalized treatment.

What does your working area (desk, office) look like and what does it say about you (or your research)? 

It is clean, organised with a touch of personal stuff. And that is exactly what my research is!

Nominate a colleague to be in the spotlight and what would you like to ask him or her?

Nielka van Erp, clinical Pharmacologist. What do we (clinicians) have to know about pharmacology?

What type of person are you, quick insights:

a) Mac or PC?                                : Mac
b) Theater or cinema?                 : Cinema
c) Dine out or dine in?                 : Dine out
d) Ferrari or Fiat?                         : Porsche
e) Shopaholic or chocoholic?     : Shopaholic
f) Culture or Nature                     : Nature

Related news items


EU funded project BIOMAP led by Ellen van den Bogaard

12 April 2019

Ellen van den Bogaard, theme Inflammatory diseases, leads the research on the experimental validation and functional analysis of identified biomarkers by using advanced organotypic skin models and receives a grant of €258,000.

read more

3D structure of the calcium channel TRPV5

11 April 2019

Cryo-Electron Microscopy provides a glance on the machinery regulating calcium transport in the kidney as published by Mark van Goor and Jenny van der Wijst, theme Renal disorders, in the journal PNAS.

read more

Rubicon grant for Linda Heskamp

9 April 2019

Linda Heskamp, theme Urological cancers, received a Rubicon grant for her project: Imaging muscle function in ALS patients.

read more

Interacting non-specific immunological effects of BCG and Tdapf vaccinations

5 April 2019

In a randomized trial Mihai Netea and colleagues aim to investigate the non-specific immunological effects of BCG and DTP-containing vaccines on the immune response to unrelated pathogens. They have published their findings in Clinical Infectious Diseases.

read more

Size matters: Miniaturised interaction proteomics with ultra-low input requirements

4 April 2019

Cristina Furlan and René Dirks from the groups of Michiel Vermeulen and Hendrik Marks, theme Cancer development and immune defense, teamed up to develop a low-input interaction proteomics platform, called on-chip AP-MS. They published these findings in Nature Communications.

read more

Internal KWF review procedure 2019

4 April 2019

In agreement with the existing policy the research board and Radboudumc Center for Oncology have decided to continue with the mandatory internal review procedure for KWF grant applications.

read more